Iovance Biotherapeutics, Inc.
METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA

Last updated:

Abstract:

Methods of treating melanomas refractory to other therapies using tumor infiltrating lymphocytes are disclosed. Also disclosed is the use of IP-10 as a biomarker for predicting treatment efficacy.

Status:
Application
Type:

Utility

Filling date:

5 Dec 2018

Issue date:

10 Mar 2022